[阿诺素在男性下泌尿道症状组合治疗中的实用用途]
R Kasyan G1,2, A Khodyreva L1,2, L Grigoryan B1,2
1Department of Urology of FGBOU VO Russian University of Medicine, Moscow, Russia.
Urologiia (Moscow, Russia : 1999)
|April 23, 2024
概括
腺素有效治疗良性前列腺增生 (BPH) 和慢性前列腺炎 (CP). 与单一疗法相比,组合疗法在改善IPSS得分和最大尿液流速方面表现出优异的结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 良性前列腺增生 (BPH) 和慢性前列腺炎 (CP) 是老年男性常见的疾病.
- 有效的治疗需要解决多种症状和潜在的病理.
- 腺素是一种用于下泌尿道症状的药物.
研究的目的:
- 为了评估阿诺普洛辛单一治疗与组合治疗的疗效.
- 为了比较患有BPH,CP或两者的患者的治疗结果.
- 评估阿诺普洛辛对尿动力学参数和验证的症状得分的影响.
主要方法:
- 在221个医疗机构中对6,442名患者进行了观察性队列研究.
- 患者接受了阿诺素作为单一疗法 (I组) 或组合疗法 (II组).
- 通过尿液流量计,前列腺体积,空白后残留体积,NIH-CPSI,IIEF-5,IPSS和QOL尺度来评估有效性.
主要成果:
- 与单一治疗相比,组合疗法在NIH-CPSI (p=0.005) 和IPSS (p<0.001) 评分中显著改善.
- 平均最大尿流速 (Qmax) 在两个组显著增加 (p<0.001).
- 腺素在单疗法和组合疗法中都对下尿路症状表现出有效性.
结论:
- 与单一治疗相比,组合疗法可以为某些BPH和CP症状提供更好的好处.
- 个性化治疗策略对于管理BPH,CP及其组合至关重要.
- 腺素是一种有效的治疗选择,无论单独使用还是结合治疗.
更多相关视频
相关概念视频
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
799
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
799
Adrenergic Agonists: Therapeutic Uses
770
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
770
Disorders of the Male Reproductive System
400
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
400
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
148
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
148
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
169
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
169
Adrenergic Agonists: Therapeutic Classification
775
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
775


